logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
W

William L. Redmond

providence cancer institute and earle a. chiles research institute and robert w. franz cancer center
H指数:33
被引数:4,986

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC)

基于新型多重免疫荧光法的肿瘤炎症评分在培美曲塞联合吉西他滨治疗既往接受过治疗的晚期非小细胞肺癌（NSCLC）的I/II期研究中提供了明显的预测性生物标志物

OncoImmunology
IF6.3
2026-05-130
OA
Rachel E. Sanborn; Shawn M. Jensen; Christopher Paustian; Shu-Ching Chang; Eloy Vetto; Quyen Vu; Venkatesh Rajamanickam; Brady Bernard; Yoshinobu Koguchi; William L. Redmond; Bernard A. Fox
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancer

淋巴周细胞因子（IRX-2）作为三阴性乳腺癌新辅助化免疫治疗前的免疫诱导

npj Breast Cancer
IF7.6
2026-03-170
OAAI
Alan Su; Erin C. Hong; Nicole Moxon; Staci L. Mellinger; Tracy Kelly; Alison K. Conlin; Zheng Zhu Topp; Philippa Newell; Nicole Fredrich; Kristen P. Massimino; Yaping Wu; Maritza Martel; William L. Redmond; Shaghayegh Aliabadi-Wahle; Zhaoyu Sun; James Imatani; Sasha E. Stanton; Douglas A. Hanes; Michael Simanonok; Wesley Rosales; Tyler J. Nielsen; David B. Page
Multi-cancer comparative multi-omics approach reveals a permissive tumor microenvironment in renal cell carcinoma through accumulation of exhausted CD8+and CD4+CD8+double positive T cells
JOURNAL OF IMMUNOLOGY
IF3.4
2025-11-010
PRE
Janghorban, Mahnaz; Koguchi, Yoshinobu; Simons, Noah; Rosales, Wesley; Rajamanickam, Venkatesh; Christie, Tanisha; Miller, William L.; Gonzalez, Iliana; Sun, Zhaoyu; Wu, Yaping; Kaur, Lakhvir; Curti, Brendan D.; Yanamandra, Niranjan; Kaufmann, Johanna; Bernard, Brady; Duhen, Thomas; Tran, Eric; Redmond, William L.
Phenotypic and clonal evolution of CD4 T cells in HNSCC during immunotherapy: a case report
JOURNAL OF IMMUNOLOGY
IF3.4
2025-11-010
PRE
Paustian, Christopher; Moudgil, Tarsem Lal; Fesneau, Olivier; Simons, Noah; Rajamanickam, Venkatesh; Koguchi, Yoshinobu; Couey, Marcus; Bernard, Brady; Christie, Tanisha; Long, Annie; Rethwisch, Patrick; Hermann, Robert; Samson, Kimberly; Redmond, William L.; Bell, Bryan; Bifulco, Carlo; Hilton, Traci; Hu, Hong-Ming; Piening, Brian; Jensen, Shawn M.; Urba, Walter John; Duhen, Thomas; Leidner, Rom; Fox, Bernard
Identification of a TCR to a non-canonical peptide (NCP) presented by the autologous non-small cell lung cancer (NSCLC) following an immunotherapy that includes canonical and NCPs 3338
JOURNAL OF IMMUNOLOGY
IF3.4
2025-11-010
PRE
Moudgil, Tarsem Lal; Hilton, Traci; Fesneau, Olivier; Shih, Yi-Ping; Paustian, Christopher; Simons, Noah; Koguchi, Yoshinobu; Rajamanickam, Venkatesh; Meng, Ryan; Bernard, Brady; Iwamoto, Noriko; Minegishi, Yuriko; Ueda, Koji; Fisher, Brenda; Tsu, Blake; Kairs, Stefanie; Barnes, Chris; Redmond, William L.; Shimada, Takashi; Bifulco, Carlo; Hu, Hong-Ming; Tran, Eric; Urba, Walter John; Duhen, Thomas; Leidner, Rom; Li, Rui; Sanborn, Rachel; Fox, Bernard
INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering

INBRX-106：一种六价OX40激动剂，可通过优化受体聚集驱动更优的抗肿瘤反应

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2025-05-210
OA
Holay, Nisha; Yadav, Rashi; Ahn, Sae Jeong; Kasiewicz, Melissa J.; Polovina, Anya; Rolig, Annah S.; Staebler, Thi; Becklund, Bryan; Simons, Noah D.; Koguchi, Yoshinobu; Eckelman, Brendan P.; de Durana, Yaiza Diaz; Redmond, William L.
Association of pathologic complete response with the 27-gene IO score and week 3 IOpath response following neoadjuvant pembrolizumab plus /intralymphatic cytokines in the neoIRX trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Page, David; Su, Alan; Moxon, Nicole; Mellinger, Staci; Kelly, Tracy; Fredrich, Nicole; Seino, Amanda; Topp, Zheng; Newell, Philippa; Massimino, Kristen; Aliabadi, Shaghayegh; Wu, Yaping; Martel, Maritza; Redmond, William; Kogushi, Yoshinobu; Mcgee, Grace; Mendez-Torres, Alejandra; Sun, Zhaoyu; Imatani, James; Conlin, Alison; Perlewitz, Kelly; Nielsen, Tyler; Stanton, Sasha
A phase II study of nivolumab plus ipilimumab and androgen receptor antagonist bicalutamide to stimulate thymic T cell generation in HER2-negative metastatic breast cancer
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Page, David; Hall, Alexander; Collins, Krystle; Moxon, Nicole; Mellinger, Staci; Kelly, Tracy; Kelley, Aysha; Fredrich, Nicole; Seino, Amanda; Liberatore, Gabriella; Conlin, Alison; Topp, Zheng; Perlewitz, Kelly; Stanton, Sasha; Urba, Walter; Wu, Yaping; Martel, Maritza; Sun, Zhaoyu; Kogushi, Yoshinobu; Redmond, William; Traina, Tiffany; Guculp, Ayca
An off-the-shelf multivalent vaccine containing cancer's dark matter, DPV-001, combined with PD-1+/- GITR in head & neck cancer: safety, efficacy, and immunodynamics from the phase 1 GITRVax trial
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Leidner, Rom S.; Paustian, Christopher; Jensen, Shawn M.; Moudgil, Tarsem; Koguchi, Yoshinobu; Simons, Noah; Rajamanickam, Venkatesh; Meng, Ryan; Couey, Marcus A.; Vu, Quyen; Taylor, Matthew H.; Long, Anne; Staeck, Abigail J.; Kaur, Lakhvir; Jovanovic, Tijana; Bernard, Brady; Christie, Tanisha; Iwamoto, Noriko; Minegishi, Yuriko; Ueda, Koji; Redmond, William; Rushforth, Lessli M.; Shimada, Takashi; Rethwisch, Patrick; Patel, Ashish; Bell, Richard B.; Bifulco, Carlo B.; Hilton, Traci L.; Hu, Hong-Ming; Piening, Brian; Urba, Walter J.; Fox, Bernard A.
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer
NPJ BREAST CANCER
IF7.6
2023-06-214
OA
Page, David B.; Pucilowska, Joanna; Chun, Brie; Kim, Isaac; Sanchez, Katherine; Moxon, Nicole; Mellinger, Staci; Wu, Yaping; Koguchi, Yoshinobu; Conrad, Valerie; Redmond, William L.; Martel, Maritza; Sun, Zhaoyu; Campbell, Mary B.; Conlin, Alison; Acheson, Anupama; Basho, Reva; McAndrew, Philomena; El-Masry, Mary; Park, Dorothy; Bennetts, Laura; Seitz, Robert S.; Nielsen, Tyler J.; McGregor, Kimberly; Rajamanickam, Venkatesh; Bernard, Brady; Urba, Walter J.; McArthur, Heather L.
Trial in progress: First-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma
CANCER RESEARCH
IF16.6
2023-04-140
PRE
Couey, Marcus A.; Taylor, Matthew; Moudgil, Tarsem; Koguchi, Yoshinobu; Stadum, Anne; Christie, Tanisha; Redmond, William L.; Paustian, Christopher; Meng, Ryan; Rajamanickam, Venkatesh; Rushforth, Lessli; Peterson, Abigail; Bernard, Brady; Bell, Richard B.; Bifulco, Carlo B.; Hilton, Traci L.; Jensen, Shawn M.; Hu, Hong-Ming; Piening, Brian; Urba, Walter J.; Fox, Bernard A.; Leidner, Rom S.
Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8+ T cell cytotoxicity over BEMPEG plus RT

bempegaldesleukin (CD122-preferential IL-2通路激动剂) 和NKTR-262 (TLR7/8激动剂) 的组合比BEMPEG加RT可改善全身抗肿瘤CD8 T细胞的细胞毒性

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2022-04-2019
OAAI
Rolig, Annah S.; Rose, Daniel C.; McGee, Grace Helen; Rubas, Werner; Kivimae, Saul; Redmond, William L.

研究方向

暂未获取到该数据
Y
Yoshinobu Koguchi
H 指数:34论文数:123被引数:3,815
B
Brady Bernard
H 指数:55论文数:175被引数:6.8万
W
Walter J. Urba
H 指数:84论文数:409被引数:6.9万
Z
Zhaoyu Sun
H 指数:13论文数:55被引数:926
M
Melissa J. Kasiewicz
H 指数:10论文数:67被引数:483
V
Venkatesh Rajamanickam
H 指数:16论文数:113被引数:1,101
D
David B. Page
H 指数:29论文数:143被引数:5,568
B
Brian Piening
H 指数:27论文数:169被引数:5,773
A
Alison Conlin
H 指数:28论文数:184被引数:6,472
M
Maritza Martel
H 指数:22论文数:88被引数:2,084